Page last updated: 2024-11-05

tranexamic acid and Angioneurotic Edema

tranexamic acid has been researched along with Angioneurotic Edema in 74 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"Ten patients with frequent attacks of non-hereditary angioedema were treated with tranexamic acid or placebo in a double blind manner, each period lasting 3 months."9.05Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years later. ( Munch, EP; Weeke, B, 1985)
"Tranexamic acid is an easily accessible and affordable therapy that may provide effective treatment for ACE inhibitor-induced episodes of angioedema."7.88[Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors]. ( Beauchêne, C; Denis, D; Maillard, H; Martin, L; Martins-Héricher, J, 2018)
"Prophylactic treatment with antifibrinolytic agents, epsilon-aminocaproic and tranexamic acid, reduces the incidence and severity of attacks in patients with hereditary angioedema."7.66Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid. ( Agostoni, A; Cicardi, M; Marasini, B; Martignoni, G; Pietrogrande, M; Uziel, L, 1978)
"Six out of 7 Finnish patients suffering from hereditary angioneurotic edema were helped during attacks, by treatment with tranexamic acid (AMCA, Cyklokapron, Kabi) in doses of 1."7.65Treatment of hereditary angioneurotic edema with tranexamic acid and cinnarizine. ( Ohela, K, 1976)
"The five members with hereditary angioneurotic edema showed: decreased values of total hemolytic activity (CH50), deficit of C4 (between 8 and 23 percent of the normal value), and normal levels of C3 and C9."6.65[Hereditary angioneurotic edema: study of serum complement and therapeutic trial with tranexamic acid (author's transl)]. ( Gallart, MT; González, JA; Martí, I; Rodrigo, MJ, 1980)
"Tranexamic acid (TXA) is an antifibrinolytic agent which reduces bradykinin production through its blockade of the conversion of plasminogen to plasmin and subsequently pre-kallikrein to kallikrein."5.72Tranexamic acid use in the setting of ACE inhibitor induced angioedema. ( Cox, C; Matusz, E; Stoldt, J, 2022)
"Tranexamic acid (TXA) is an antifibrinolytic agent which inhibits conversion of plasminogen to plasmin, a key step in kallikrein activation and bradykinin formation."5.62Tranexamic acid for ACE inhibitor induced angioedema. ( Geiger, H; McMahon, A; Wang, K, 2021)
"Tranexamic acid appears to be a reasonable adjunct for the emergency medicine clinician to consider in the management of many hemorrhagic conditions and angiotensin converting enzyme inhibitor-induced angioedema."5.22Tranexamic acid - A narrative review for the emergency medicine clinician. ( Santiago, R; Wang, K, 2022)
"Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases."5.05The emerging importance of tranexamic acid in dermatology. ( Al-Niaimi, F; Ali, FR; Forbat, E, 2020)
"Acquired angioedema with C1-inhibitor deficiency is a rare and peculiar entity belonging to the spectrum of bradykinin angioedemas."5.05[Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment]. ( Armengol, G; Boccon-Gibod, I; Bouillet, L; Coppo, P; Defendi, F; Du-Thanh, A; Fain, O; Gobert, D; Hardy, G; Javaud, N; Jeandel, PY; Launay, D; Panayotopoulos, V; Pelletier, F, 2020)
"Ten patients with frequent attacks of non-hereditary angioedema were treated with tranexamic acid or placebo in a double blind manner, each period lasting 3 months."5.05Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years later. ( Munch, EP; Weeke, B, 1985)
"Non-hereditary angioedema (AE) with normal C1 esterase inhibitor (C1INH) can be presumably bradykinin- or mast cell-mediated, or of unknown cause."4.98Efficacy of Treatment of Non-hereditary Angioedema. ( Blankestijn, MA; Go, MFCL; Knulst, AC; Otten, HG; van den Elzen, M; van Os-Medendorp, H, 2018)
" A combination of aprotinin with tranexamic acid may be effective in preventing or delaying rebleeding after rupture of an intracerebral aneurysm; the addition of aprotinin seems to decrease the incidence of delayed cerebral vasospasm and ischaemic complications which are sometimes noted when tranexamic acid alone is used."4.77Clinical application of inhibitors of fibrinolysis. ( Verstraete, M, 1985)
"Tranexamic acid is an easily accessible and affordable therapy that may provide effective treatment for ACE inhibitor-induced episodes of angioedema."3.88[Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors]. ( Beauchêne, C; Denis, D; Maillard, H; Martin, L; Martins-Héricher, J, 2018)
"Although there are no approved treatments for idiopathic angioedema, several medications used for the treatment of hereditary angioedema, such as bradykinin receptor antagonists (icatibant), kallikrein inhibitors (ecallantide), and C1 inhibitors, were successful in 10 patients."3.81Current treatment options for idiopathic angioedema. ( Hanson, J; Portnoy, J; Shroba, J, 2015)
"When a non-histaminergic angioedema is suspected, tranexamic acid must be proposed as attack's treatment and as prophylactic treatment."3.72[Non-histaminic angiodema management: diagnostic and therapeutic interest of tranexamic acid]. ( Bouillet, L; Drouet, C; Massot, C; Ponard, D, 2004)
"We sought to describe the characteristics of a group of patients with idiopathic nonhistaminergic angioedema and their response to prophylactic treatment with tranexamic acid."3.70Idiopathic nonhistaminergic angioedema. ( Agostoni, A; Bergamaschini, L; Cicardi, M; Gioffré, D; Zingale, LC, 1999)
" Prophylaxis against angioneurotic oedema using danazol and tranexamic acid is described and the resultant complication of mesenteric venous thrombosis reported."3.67Acquired C1 esterase inhibitor deficiency. ( Coulson, IH; Findley, IL; Gould, TR; Razis, PA, 1986)
"Prophylactic treatment with antifibrinolytic agents, epsilon-aminocaproic and tranexamic acid, reduces the incidence and severity of attacks in patients with hereditary angioedema."3.66Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid. ( Agostoni, A; Cicardi, M; Marasini, B; Martignoni, G; Pietrogrande, M; Uziel, L, 1978)
"Six out of 7 Finnish patients suffering from hereditary angioneurotic edema were helped during attacks, by treatment with tranexamic acid (AMCA, Cyklokapron, Kabi) in doses of 1."3.65Treatment of hereditary angioneurotic edema with tranexamic acid and cinnarizine. ( Ohela, K, 1976)
"The five members with hereditary angioneurotic edema showed: decreased values of total hemolytic activity (CH50), deficit of C4 (between 8 and 23 percent of the normal value), and normal levels of C3 and C9."2.65[Hereditary angioneurotic edema: study of serum complement and therapeutic trial with tranexamic acid (author's transl)]. ( Gallart, MT; González, JA; Martí, I; Rodrigo, MJ, 1980)
"Hereditary angioneurotic edema (HAE) is an autosomal dominant disease caused by a deficiency of a complement regulatory protein, the C1INH."2.38[Clinical contribution to the problem of correlations between hereditary angioneurotic edema and pregnancy]. ( Barrile, A; Bonanno, D; Crisafi, A; Ferlazzo, B; Ferrari, U; Quattrocchi, P; Sorge, R, 1990)
"Tranexamic acid (TXA) is an antifibrinolytic agent which reduces bradykinin production through its blockade of the conversion of plasminogen to plasmin and subsequently pre-kallikrein to kallikrein."1.72Tranexamic acid use in the setting of ACE inhibitor induced angioedema. ( Cox, C; Matusz, E; Stoldt, J, 2022)
"Tranexamic acid (TXA) is an antifibrinolytic agent which inhibits conversion of plasminogen to plasmin, a key step in kallikrein activation and bradykinin formation."1.62Tranexamic acid for ACE inhibitor induced angioedema. ( Geiger, H; McMahon, A; Wang, K, 2021)
"We aimed to study the subgroups of hereditary angioedema with FXII mutation (FXII-HAE), unknown genetic defect (U-HAE) and idiopathic non-histaminergic acquired angioedema (InH-AAE)."1.42Characterization of patients with angioedema without wheals: the importance of F12 gene screening. ( Bafunno, V; Barca, MP; Del Giacco, SR; Firinu, D; Manconi, PE; Margaglione, M; Santacroce, R; Vecchione, G, 2015)
"Hereditary angioneurotic edema is a dominant autosomal disease (incidence 1/150,000), whose diagnosis is crucial as this condition can lead to fatal asphyxia within minutes."1.33[Hereditary angioneurotic edema: a case report in a 3-year-old child]. ( Amiour, M; El-Hachem, C; Guillot, M; Laurent, J, 2005)
"Hereditary angioneurotic edema results from the deficiency of C1-esterase inhibitor."1.31[Hereditary angioneurotic edema in children]. ( Farkas, H; Füst, G; Harmat, G; Varga, L; Visy, B, 2000)
" C 1 esterase inhibitor concentrate proved highly effective in the treatment of acute attacks (the result was lacking in one patient because of too low dosage of the drug)."1.26Treatment of hereditary angioedema. ( Agostoni, A; Cicardi, M; Marasini, B; Martignoni, GC, 1978)

Research

Studies (74)

TimeframeStudies, this research(%)All Research%
pre-199034 (45.95)18.7374
1990's9 (12.16)18.2507
2000's12 (16.22)29.6817
2010's11 (14.86)24.3611
2020's8 (10.81)2.80

Authors

AuthorsStudies
Stoldt, J1
Cox, C1
Matusz, E1
Wang, K2
Santiago, R1
Wu, YH1
Tsai, KC1
Ho, MP1
Forbat, E1
Al-Niaimi, F1
Ali, FR1
Gobert, D1
Bouillet, L3
Armengol, G1
Coppo, P1
Defendi, F1
Du-Thanh, A2
Hardy, G1
Javaud, N1
Jeandel, PY1
Launay, D1
Panayotopoulos, V1
Pelletier, F1
Boccon-Gibod, I1
Fain, O1
Grewal, E1
Sutarjono, B1
Mohammed, I1
Geiger, H1
McMahon, A1
Martinez Manzano, JM1
Lo, KB1
Patarroyo-Aponte, G1
Azmaiparashvili, Z1
Beauchêne, C1
Martins-Héricher, J1
Denis, D1
Martin, L1
Maillard, H1
Magen, E1
Chikovani, T1
Mori, T1
Matsusita, H1
Takahasi, H1
Iida, H1
Kato, K1
Yukawa, T1
Fujiki, Y1
Namiki, T1
Numata, Y1
Nishio, K1
Vincent, D1
Ponard, D4
Fiorella, S1
Drouet, C5
Firinu, D1
Bafunno, V1
Vecchione, G1
Barca, MP1
Manconi, PE1
Santacroce, R1
Margaglione, M1
Del Giacco, SR1
Shroba, J1
Hanson, J1
Portnoy, J1
van den Elzen, M1
Go, MFCL1
Knulst, AC1
Blankestijn, MA1
van Os-Medendorp, H1
Otten, HG1
Edalati, K1
Roesch, MT1
Buchanan, ML1
Teeter, M1
Maberley, DA1
Raison-Peyron, N1
Guillot, B1
Nakaigawa, N1
Kamata, K1
Komatsu, R1
Ozaki, M1
Maruta, T1
Tateishi, M1
Fujie, Y1
Maruta, N1
Yamauchi, K1
Yano, T1
Kawano, T1
Tsuneyoshi, I1
Hosotte, M1
Jarlot, S1
Luyasu, S1
Kanny, G1
Farkas, H2
Harmat, G2
Füst, G2
Varga, L2
Visy, B2
Bouillet-Claveyrolas, L1
Massot, C2
Ritchie, BC1
El-Hachem, C1
Amiour, M1
Guillot, M1
Laurent, J1
Reiss, M1
Reiss, G1
Rousset, H1
Cichon, S1
Pedraz, J1
Daudén, E1
García-Diez, A1
Fiz Matías, J1
Ferrer Cerón, SM1
García Pérez, C1
Marcos Vidal, JM1
Guerrero, M1
Prieto, L1
Basomba, A1
Campos, A1
Peláez, A1
García Villalmanzo, I1
Kodama, J1
Uchida, K1
Yoshimura, S1
Katayama, Y1
Kushiro, H1
Yutani, C1
Funahashi, S1
Takamiya, O1
Matsumoto, Y1
Ando, Y1
Gross, DJ1
Gur, H1
Dunsky, EH1
Fabiani, JE2
Simkin, G1
Freed, DL1
Buisseret, PD1
Lloyd, MJ1
Pumphrey, RS1
Garretts, M1
González, JA1
Gallart, MT1
Martí, I1
Rodrigo, MJ1
Theil, PL1
Walls, RS1
Ordman, L1
Cugno, M1
Cicardi, M5
Agostoni, A5
da Costa, JT1
da Silva, JM1
Cunha, L1
Castel-Branco, MG1
Azevedo, MV1
Novoa González, J1
Pérez Losada, AJ1
García Burriel, JI1
Jordano Montenegro, J1
Antelo Cortizas, J1
Castelli, R1
Gardinali, M1
Zingale, LC2
Savi, C1
Munari, M1
Göring, HD1
Bork, K1
Späth, PJ1
Bauer, R1
Ziemer, A1
Hintner, H1
Wüthrich, B1
Bergamaschini, L1
Gioffré, D1
Chadenat, ML1
Morelon, S1
Dupont, C1
Dorra, M1
Rouveix, E1
Ohela, K1
Davies, D1
Howell, DA1
Naish, P1
Barratt, J1
Kondo, M1
Marasini, B2
Martignoni, GC1
Spragg, J1
Laurberg, G2
Thompson, RA1
Felix-Davies, DD1
Martignoni, G1
Uziel, L1
Pietrogrande, M1
Sheffer, AL1
Fearon, DT1
Austen, KF1
Rosen, FS1
Sundin, B1
Benterud, JG1
Bosley, AR1
Zachariae, H1
Hjortshoj, A1
Casali, P1
Rugarli, C1
Zanussi, C1
Streuli, R1
Grob, P1
Frank, MM1
Gelfand, JA1
Atkinson, JP1
Danieli, R1
Pesce, M1
Vizzoni, L1
Birgerson, L1
Ferlazzo, B1
Barrile, A1
Bonanno, D1
Crisafi, A1
Ferrari, U1
Quattrocchi, P1
Sorge, R1
Verstraete, M1
Richardson, SG1
Clarke, CW1
Gasson, GB1
Håkansson, OM1
Crosher, R1
Razis, PA1
Coulson, IH1
Gould, TR1
Findley, IL1
Munch, EP1
Weeke, B1
Simkin, GO1
Leoni, J1
Squiquera, L1
Mathov, E1
Jones, L1
Bubel, MA1
Newland, AC1
Klepper, KE1
Gahlen, W1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department[NCT06096077]50 participants (Actual)Observational2022-11-30Completed
Adaptative Servoventilation Compliance in Left Ventricular Dysfunction Patients With Central Sleep Apnea: Benefit of One Month Hypnotic (Zopiclone) Versus Placebo[NCT02820441]Phase 42 participants (Actual)Interventional2016-05-31Terminated
[NCT02854397]31 participants (Actual)Observational2016-02-15Terminated (stopped due to Recruitment difficulties)
Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599]40 participants (Actual)Interventional2011-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for tranexamic acid and Angioneurotic Edema

ArticleYear
Tranexamic acid - A narrative review for the emergency medicine clinician.
    The American journal of emergency medicine, 2022, Volume: 56

    Topics: Angioedema; Antifibrinolytic Agents; Emergency Medicine; Gastrointestinal Hemorrhage; Humans; Tranex

2022
The emerging importance of tranexamic acid in dermatology.
    Clinical and experimental dermatology, 2020, Volume: 45, Issue:4

    Topics: Angioedema; Antifibrinolytic Agents; Dermatology; Hemorrhage; Humans; Melanosis; Pigmentation Disord

2020
[Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment].
    La Revue de medecine interne, 2020, Volume: 41, Issue:12

    Topics: Angioedema; Angioedemas, Hereditary; Bradykinin; Chemoprevention; Comorbidity; Diagnosis, Differenti

2020
Efficacy of Treatment of Non-hereditary Angioedema.
    Clinical reviews in allergy & immunology, 2018, Volume: 54, Issue:3

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Humans; Omalizumab; Progestins; Tr

2018
[Quincke's oedema or angioedema].
    La Revue du praticien, 2012, Volume: 62, Issue:2

    Topics: Angioedema; Antifibrinolytic Agents; Bradykinin; Contraindications; Danazol; Estrogen Antagonists; H

2012
Clinical management of hereditary angio-oedema in children.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2002, Volume: 13, Issue:3

    Topics: Adolescent; Aminocaproic Acid; Angioedema; Child; Child, Preschool; Complement C1 Inactivator Protei

2002
Protease inhibitors in the treatment of hereditary angioedema.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2003, Volume: 29, Issue:3

    Topics: Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Aprotinin; Clinical Trials as Topic; Complem

2003
[Angioedema. Cause, clinical presentation, diagnosis and treatment].
    Medizinische Monatsschrift fur Pharmazeuten, 2007, Volume: 30, Issue:1

    Topics: Angioedema; Antifibrinolytic Agents; Glucocorticoids; Humans; Hypersensitivity; Tranexamic Acid

2007
[Practical management of C1 inhibitor deficiency].
    Actas dermo-sifiliograficas, 2007, Volume: 98, Issue:4

    Topics: Adolescent; Adult; Aminocaproic Acid; Angioedema; Bradykinin; Child; Child, Preschool; Complement C1

2007
[Correlation of complement system with coagulation, fibrinolysis, and kinin generation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1976, Volume: 17, Issue:1

    Topics: Adult; Aminocaproates; Angioedema; Animals; Antigen-Antibody Complex; Antigen-Antibody Reactions; Bl

1976
[Clinical contribution to the problem of correlations between hereditary angioneurotic edema and pregnancy].
    Minerva ginecologica, 1990, Volume: 42, Issue:9

    Topics: Adult; Angioedema; Contraindications; Female; Humans; Infant, Newborn; Pedigree; Pregnancy; Pregnanc

1990
Clinical application of inhibitors of fibrinolysis.
    Drugs, 1985, Volume: 29, Issue:3

    Topics: 4-Aminobenzoic Acid; Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Aprotinin; Blood Preser

1985

Trials

3 trials available for tranexamic acid and Angioneurotic Edema

ArticleYear
[Hereditary angioneurotic edema: study of serum complement and therapeutic trial with tranexamic acid (author's transl)].
    Medicina clinica, 1980, Jun-10, Volume: 75, Issue:1

    Topics: Angioedema; Child; Clinical Trials as Topic; Complement System Proteins; Cyclohexanecarboxylic Acids

1980
Menstruation-related angioedema treated with tranexamic acid.
    Acta obstetricia et gynecologica Scandinavica, 1988, Volume: 67, Issue:6

    Topics: Adult; Angioedema; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Female; Humans; Menstruati

1988
Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years later.
    Allergy, 1985, Volume: 40, Issue:2

    Topics: Adult; Aged; Angioedema; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diarrhea; Digestive

1985

Other Studies

59 other studies available for tranexamic acid and Angioneurotic Edema

ArticleYear
Tranexamic acid use in the setting of ACE inhibitor induced angioedema.
    The American journal of emergency medicine, 2022, Volume: 55

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Humans; Kallikreins; Tranexamic Ac

2022
Tranexamic acid use for ACE inhibitor induced angioedema.
    The American journal of emergency medicine, 2022, Volume: 59

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Humans; Tranexamic Acid

2022
Angioedema, ACE inhibitor and COVID-19.
    BMJ case reports, 2020, Sep-09, Volume: 13, Issue:9

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Allergic Agents; Benzazepines; Betacorona

2020
Tranexamic acid for ACE inhibitor induced angioedema.
    The American journal of emergency medicine, 2021, Volume: 43

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antifibrinolytic Agents; Female; Humans; Lisin

2021
The use of intravenous tranexamic acid for patients with angiotensin-converting enzyme inhibitor-induced angioedema: A case series.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021, Volume: 126, Issue:6

    Topics: Administration, Intravenous; Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antifibrino

2021
[Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors].
    La Revue de medecine interne, 2018, Volume: 39, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Em

2018
Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:7

    Topics: Adult; Angioedema; Anti-Allergic Agents; Antifibrinolytic Agents; Chronic Disease; Female; Humans; I

2018
[Case report; a case of hereditary angioedema with laryngeal edema leading to suffocation].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2013, Oct-10, Volume: 102, Issue:10

    Topics: Airway Management; Angioedema; Antifibrinolytic Agents; Asphyxia; Bronchoscopy; Complement C1 Inhibi

2013
Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2015, Volume: 114, Issue:1

    Topics: Aged; Angioedema; Angioedemas, Hereditary; Antibodies, Blocking; Autoantibodies; Autoimmunity; Compl

2015
Characterization of patients with angioedema without wheals: the importance of F12 gene screening.
    Clinical immunology (Orlando, Fla.), 2015, Volume: 157, Issue:2

    Topics: Adolescent; Adult; Aged; Angioedema; Angioedemas, Hereditary; Antifibrinolytic Agents; Bradykinin; B

2015
Current treatment options for idiopathic angioedema.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2015, Volume: 115, Issue:5

    Topics: Adolescent; Angioedema; Antibodies, Anti-Idiotypic; Bradykinin; Female; Humans; Peptides; Tranexamic

2015
Central serous chorioretinopathy and idiopathic nonhistaminergic angioedema.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:5

    Topics: Adult; Angioedema; Antifibrinolytic Agents; Capillary Permeability; Choroid; Fluorescein Angiography

2009
Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema.
    Allergy, 2010, Jun-01, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Aged; Angioedema; Bradykinin; Child; Child, Preschool; Female; Humans; Infant; Ma

2010
[Perioperative management of a patient complicated with Quincke's edema].
    Masui. The Japanese journal of anesthesiology, 2010, Volume: 59, Issue:4

    Topics: Aneurysm, Ruptured; Angioedema; Chlorpheniramine; Craniotomy; Humans; Intracranial Aneurysm; Intubat

2010
[Anesthesia and perioperative management in a patient with acquired angioedema].
    Masui. The Japanese journal of anesthesiology, 2011, Volume: 60, Issue:7

    Topics: Anesthesia, Epidural; Anesthesia, Spinal; Angioedema; Complement C1 Inhibitor Protein; Female; Human

2011
Clinical and biological distinctions between type I and type II acquired angioedema.
    The American journal of medicine, 2003, Oct-01, Volume: 115, Issue:5

    Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Autoantibodies; Complement C1 Inactivator Prot

2003
[Non-histaminic angiodema management: diagnostic and therapeutic interest of tranexamic acid].
    La Revue de medecine interne, 2004, Volume: 25, Issue:12

    Topics: Adolescent; Adult; Angioedema; Female; Humans; Male; Tranexamic Acid

2004
[Hereditary angioneurotic edema: a case report in a 3-year-old child].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:8

    Topics: Adrenergic Agonists; Angioedema; Anti-Inflammatory Agents; Antifibrinolytic Agents; Asthma; Child, P

2005
[Hereditary angioneurotic edema: a case report in a 3-year-old child].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:8

    Topics: Adrenergic Agonists; Angioedema; Anti-Inflammatory Agents; Antifibrinolytic Agents; Asthma; Child, P

2005
[Hereditary angioneurotic edema: a case report in a 3-year-old child].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:8

    Topics: Adrenergic Agonists; Angioedema; Anti-Inflammatory Agents; Antifibrinolytic Agents; Asthma; Child, P

2005
[Hereditary angioneurotic edema: a case report in a 3-year-old child].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:8

    Topics: Adrenergic Agonists; Angioedema; Anti-Inflammatory Agents; Antifibrinolytic Agents; Asthma; Child, P

2005
A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene.
    The British journal of dermatology, 2007, Volume: 156, Issue:5

    Topics: Angioedema; Antifibrinolytic Agents; Complement C1 Inhibitor Protein; Female; Humans; Pregnancy; Pre

2007
[Obstetric analgesia for a women with type III hereditary angioneurotic edema].
    Revista espanola de anestesiologia y reanimacion, 2007, Volume: 54, Issue:4

    Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Local; Angioedema; Antifibrinolytic

2007
[Familial angioedema (II). Treatment].
    Medicina clinica, 1984, Jun-02, Volume: 83, Issue:1

    Topics: Aminocaproic Acid; Angioedema; Cinnarizine; Complement C1 Inactivator Proteins; Danazol; Histamine H

1984
Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.
    Blut, 1984, Volume: 49, Issue:5

    Topics: Angioedema; Coagulants; Cold Temperature; Complement C1 Inactivator Proteins; Complement System Prot

1984
[Hereditary angio-edema].
    Harefuah, 1984, Feb-01, Volume: 106, Issue:3

    Topics: Adult; Angioedema; Child; Complement C1 Inactivator Proteins; Danazol; Female; Humans; Tranexamic Ac

1984
[Familial hereditary angioedema].
    Alergia, 1983, Volume: 30, Issue:1

    Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Tranexamic Acid

1983
Angioedema responding to antiprotease treatment but without abnormalities of the complement system.
    Clinical allergy, 1980, Volume: 10, Issue:1

    Topics: Adult; Aminocaproates; Angioedema; Blood Coagulation Tests; Complement C1; Complement C3; Complement

1980
Ophthalmological examination of patients in long-term treatment with tranexamic acid.
    Acta ophthalmologica, 1981, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Aged; Angioedema; Color Perception Tests; Cornea; Cyclohexanecarboxylic Acids; Fe

1981
Clinical presentation and diagnosis of hereditary angio-oedema in five families.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1981, Oct-31, Volume: 60, Issue:18

    Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Complement System Proteins; Female; Humans; M

1981
Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.
    The Journal of allergy and clinical immunology, 1994, Volume: 93, Issue:5

    Topics: Acute Disease; Aged; Angioedema; Autoantibodies; Autoimmune Diseases; Complement C1 Inactivator Prot

1994
Hereditary angioedema presenting with adult respiratory distress syndrome.
    Chest, 1994, Volume: 105, Issue:6

    Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Danazol; Humans; Laryngeal Edema; Male; Respi

1994
[Hereditary angioedema. Diagnosis and treatment during childhood].
    Anales espanoles de pediatria, 1993, Volume: 38, Issue:5

    Topics: Age Factors; Angioedema; Child, Preschool; Complement C1 Inactivator Proteins; Female; Humans; Trane

1993
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.
    The International journal of artificial organs, 1997, Volume: 20, Issue:3

    Topics: Aged; Anabolic Agents; Angioedema; Antifibrinolytic Agents; Aprotinin; Autoimmune Diseases; Calcium

1997
[Hereditary angioedema in the German-speaking region].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1998, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Angioedema; Child; Child, Preschool; Complement C1 Inactivator Proteins; Danazol;

1998
Idiopathic nonhistaminergic angioedema.
    The American journal of medicine, 1999, Volume: 106, Issue:6

    Topics: Adolescent; Adult; Aged; Angioedema; Antifibrinolytic Agents; Complement System Proteins; Female; Hi

1999
[Acquired angioneurotic edema: association with hydatidosis].
    Presse medicale (Paris, France : 1983), 2000, Sep-16, Volume: 29, Issue:16

    Topics: Angioedema; Antifibrinolytic Agents; Danazol; Echinococcosis; Estrogen Antagonists; Follow-Up Studie

2000
[Hereditary angioneurotic edema in children].
    Orvosi hetilap, 2000, Nov-19, Volume: 141, Issue:47

    Topics: Adolescent; Angioedema; Child; Child, Preschool; Complement C1 Inactivator Proteins; Danazol; Diagno

2000
Treatment of hereditary angioneurotic edema with tranexamic acid and cinnarizine.
    Acta dermato-venereologica, 1976, Volume: 56, Issue:1

    Topics: Adult; Aged; Angioedema; Cyclohexanecarboxylic Acids; Fatigue; Female; Follow-Up Studies; Humans; Ma

1976
Tranexamic acid and arterial thrombosis.
    Lancet (London, England), 1977, Jan-01, Volume: 1, Issue:8001

    Topics: Adult; Angioedema; Arteritis; Carotid Artery Thrombosis; Cyclohexanecarboxylic Acids; Female; Humans

1977
Hereditary angiooedema.
    Lancet (London, England), 1979, Mar-17, Volume: 1, Issue:8116

    Topics: Adult; Age Factors; Aged; Angioedema; Danazol; Female; Humans; Male; Middle Aged; Pregnancy; Pregnan

1979
Treatment of hereditary angioedema.
    Klinische Wochenschrift, 1978, Aug-15, Volume: 56, Issue:16

    Topics: Adolescent; Adult; Aged; Angioedema; Aprotinin; Child; Complement C1 Inactivator Proteins; Female; H

1978
Specific functional and immunologic assay of plasma plasminogen in hereditary angioedema, in hereditary angioedema treated with tranexamic acid, and in normal subjects.
    Journal of immunology (Baltimore, Md. : 1950), 1978, Volume: 120, Issue:2

    Topics: Angioedema; Antigens; Cyclohexanecarboxylic Acids; Humans; Plasminogen; Tranexamic Acid

1978
Plasma kinin activation in tranexamic acid treated patients with hereditary angioneurotic edema.
    Archives of dermatological research, 1978, Jul-28, Volume: 262, Issue:2

    Topics: Adult; Aged; Angioedema; Cyclohexanecarboxylic Acids; Factor XII; Female; Humans; Kinins; Male; Midd

1978
Response of "idiopathic" recurrent angioneurotic oedema to tranexamic acid.
    British medical journal, 1978, Aug-26, Volume: 2, Issue:6137

    Topics: Adult; Angioedema; Cyclohexanecarboxylic Acids; Female; Humans; Recurrence; Tranexamic Acid

1978
Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid.
    Allergy, 1978, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Alanine Transaminase; Angioedema; Aspartate Aminotransferases; Bilirubin; Child;

1978
Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema.
    The Journal of allergy and clinical immunology, 1977, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Angioedema; Cyclohexanecarboxylic Acids; Gastrectomy; Humans; Hysterectomy; Middl

1977
[A case of non-hereditary angioneurotic edema treated with tranexamic acid].
    Lakartidningen, 1977, Sep-14, Volume: 74, Issue:37

    Topics: Angioedema; Cyclohexanecarboxylic Acids; Female; Humans; Middle Aged; Tranexamic Acid

1977
[Hereditary angioneurotic edema].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1976, Nov-10, Volume: 96, Issue:31

    Topics: Angioedema; Child; Child, Preschool; Female; Humans; Male; Prognosis; Tranexamic Acid

1976
Familial anglo-oedema--a particularly severe form.
    Postgraduate medical journal, 1976, Volume: 52, Issue:613

    Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Humans; Male; Pedigree; Tranexamic Acid

1976
[Tranexamic acid (Cyclokapron) in hereditary angioneurotic edema].
    Ugeskrift for laeger, 1975, May-12, Volume: 137, Issue:20

    Topics: Adolescent; Adult; Aged; Angioedema; Child; Cyclohexanecarboxylic Acids; Female; Humans; Male; Middl

1975
A study of complement functions in a family with hereditary angioneurotic edema.
    Bollettino dell'Istituto sieroterapico milanese, 1975, Nov-20, Volume: 54, Issue:5

    Topics: Adolescent; Adult; Angioedema; Complement C1; Complement C3; Complement System Proteins; Enzyme Inhi

1975
[Study of a large family with hereditary angioneurotic edema].
    Schweizerische medizinische Wochenschrift, 1975, Oct-25, Volume: 105, Issue:43

    Topics: Adolescent; Adult; Aged; Angioedema; Complement C1; Complement C3; Complement Inactivator Proteins;

1975
Hereditary angioedema: the clinical syndrome and its management.
    Annals of internal medicine, 1976, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Aged; Aminocaproates; Angioedema; Blood Transfusion; Child; Complement Inactivato

1976
[Hereditary angioedema. Description of a pediatric case].
    Minerva pediatrica, 1991, Volume: 43, Issue:11

    Topics: Angioedema; Child, Preschool; Esterases; Humans; Male; Tranexamic Acid

1991
Tranexamic acid in the treatment of hereditary angioedema.
    The American journal of medicine, 1991, Volume: 91, Issue:1

    Topics: Angioedema; Drug and Narcotic Control; Humans; Tranexamic Acid; United States; United States Food an

1991
Lymphocytic lymphoma and acquired C1 esterase inhibitor deficiency.
    The British journal of dermatology, 1989, Volume: 120, Issue:1

    Topics: Angioedema; Complement C1 Inactivator Proteins; Complement C3; Complement C4; Female; Humans; Leukem

1989
Intravenous tranexamic acid in the management of hereditary angio-oedema.
    The British journal of oral & maxillofacial surgery, 1987, Volume: 25, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Angioedema; Cyclohexanecarboxylic Acids; Diseases in Twins;

1987
Acquired C1 esterase inhibitor deficiency.
    Anaesthesia, 1986, Volume: 41, Issue:8

    Topics: Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Mesenteric Vascular Occlusion; Middl

1986
Hereditary angioedema: polymorphism.
    Annals of allergy, 1985, Volume: 55, Issue:6

    Topics: Adolescent; Adult; Aminocaproates; Angioedema; Danazol; Female; Humans; Levamisole; Male; Polymorphi

1985
C1 esterase inhibitor as a possible tumour marker in malignant lymphoma.
    Clinical and laboratory haematology, 1985, Volume: 7, Issue:3

    Topics: Angioedema; Chlorambucil; Chlorpheniramine; Complement C1 Inactivator Proteins; Humans; Lymphoma; Ma

1985
[Hereditary angioneurotic edema].
    Zeitschrift fur Hautkrankheiten, 1974, Sep-15, Volume: 49, Issue:18

    Topics: Adult; Aged; Aminocaproates; Angioedema; Complement C1; Enzyme Inhibitors; Esterases; Female; Humans

1974
chemdatabank.com